Jan 16th, 2021 - Immunocompromised populations are at great risk of the current 2020 global emergency of coronavirus disease 2019 (COVID-19), and treatment of kidney transplant recipients with COVID-19 is currently not declared. Hence, the purpose of the study is to set a clear treatment regimen. We report here a therapeutic course of 2 patients who underwent transplant surgery in March 2020 and got infected so...

Jan 16th, 2021 - In liver transplant (LT) recipients with severe coronavirus disease 2019 (COVID-19), fatal outcome has been reported in a substantial subset of patients. Whether LT recipients are at increased risk for severe COVID-19 compared with the general population is controversial. Here we report the results of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey in a large LT recipi...

Jan 16th, 2021 - COVID-19 narratives from the New York Roentgen Society.|2021|Nwawka OK,Katzen JT,|

Jan 16th, 2021 - As the novel severe acute respiratory syndrome coronavirus-2 related pandemic - Corona Virus Disease 2019 (COVID-19) has emerged, decision making in the context of cancer treatment has become more complex. The apprehension of using drugs that could adversely affect infected patients, the risk of not using life-saving treatments and the complexities related to the type of cancer itself, all must...

Jan 16th, 2021 - Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination.|2021|Torjesen I,|

Jan 16th, 2021 - Covid-19: Japan declares second state of emergency as Asia struggles with virus surge.|2021|Looi MK,|

Jan 16th, 2021 - To determine the indirect consequences of the COVID-19 pandemic on paediatric healthcare utilisation and severe disease at a national level following lockdown on 23 March 2020. National retrospective cohort study. Emergency childhood primary and secondary care providers across Scotland; two national paediatric intensive care units (PICUs); statutory death records. 273 455 unscheduled primary ca...

Jan 16th, 2021 - Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Yang et al.|2021|Akiyama S,Hamdeh S,Micic D,Sakuraba A,|

Jan 16th, 2021 - The immunomodulatory effects of immune checkpoint blockade (ICB) therapy for cancer may act at the crossroads between the need to increase anti-viral immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and to decrease the inflammatory responses in severe cases of coronavirus disease 2019 (COVID-19). There is evidence from preclinical models that blocking programmed d...

Jan 16th, 2021 - Covid-19: Doctors' leaders call for revised PPE guidance to reflect new variants.|2021|Iacobucci G,|

Jan 16th, 2021 - Covid-19: Government uses lateral flow tests to keep children in schools against regulator's advice.|2021|Wise J,|

Jan 16th, 2021 - Emergency Medicine Journal COVID-19 monthly top five.|2021|Horner D,O'Rourke J,Collins J,Darbyshire D,Lecky F,|

Jan 16th, 2021 - A 53-year-old man with diabetes came to the emergency department with fever and dry cough for 5 days, swelling of the left leg for 2 days, shortness of breath and chest pain for 1 hour. He had raised temperature, tachycardia, tachypnoea, reduced oxygen saturation and swollen tender left leg on examination. The frontal chest radiograph showed bilateral ground-glass opacities; he tested positive ...

Jan 16th, 2021 - The goals of this review are to evaluate the impact of socioeconomic (SE) status on the general health and cardiovascular health of individuals during the COVID-19 pandemic and also discuss the measures to address disparity. SE status is a strong predictor of premature morbidity and mortality within general health. A lower SE status also has implications of increased cardiovascular disease (CVD...

Jan 16th, 2021 - The quality of healthcare service websites gains particular importance in the time of the pandemic, asthe popularity of electronic services grows. This applies to infectious disease hospitals as well, often on the front line of the effort against COVID-19. The paper aims to assess the quality of infectious disease hospital websites in Poland in light of the COVID-19 pandemic. The research cover...

Jan 16th, 2021 - An EUA for casirivimab and imdevimab for COVID-19.|2021||

Jan 16th, 2021 - An EUA for baricitinib (Olumiant) for COVID-19.|2021||

Jan 16th, 2021 - COVID-19 caused some worries among pregnant women. Worries during pregnancy can affect women's well-being. We investigated worry and well-being and associated factors among pregnant women during the COVID-19 pandemic. This descriptive cross-sectional study was conducted on 484 pregnant women using an online questionnaire. Sampling was performed in a period between May 5 and Aug 5, 2020. Inclusi...

Jan 16th, 2021 - The actual SARS-CoV-2 outbreak caused a highly transmissible disease with a tremendous impact on elderly people. So far, few studies focused on very elderly patients (over 80 years old). In this study we examined the clinical presentation and the outcome of the disease in this group of patients, admitted to our Hospital in Rome. This is a single-center, retrospective study performed in the Sant...

Jan 16th, 2021 - COVID19 is a respiratory disease caused by a novel coronavirus. As there has been no definitive treatment for the disease so far, the only way to control the spread is to break the chain of infection. Our study aimed to analyze the preventive behaviors and influencing factors in the Iranian population. This cross-sectional study was a web-based survey in the Iranian population. We performed the...